濱田 洋通
   Department   Other, Other
   Position  
Article types Original article
Language English
Peer review Peer reviewed
Title Efficacy of primary treatment with immunoglobulin plus cyclosporine for prevention of coronary artery abnormalities in Kawasaki disease patients predicted to be at increased risk of IVIG non-response (KAICA study): a controlled, phase 3, randomised, open-label, blinded-endpoints trial
Journal Formal name:Lancet
Abbreviation:Lancet
ISSN code:01406736/1474547X
Domestic / ForeginForegin
Volume, Issue, Page 393(10176),pp.1128-1137
Author and coauthor Hamada Hiromichi
Authorship Lead author
Publication date 2019/03
DOI 10.1016/S0140-6736(18)32003-8